Evaluation of the cardiovascular effects of methylmercury exposures: Current evidence supports development of a dose-response function for regulatory benefits analysis

Environmental Health Perspectives

Volumn 119, Issue 5, 2011, Pages 607-614

  Roman, Henry A ^a   Walsh, Tyra L ^a   Coull, Brent A ^b   Dewailly, Éric ^c   Guallar, Eliseo ^d,e   Hattis, Dale ^f   Mariën, Koenraad ^g   Schwartz, Joel ^b   Stern, Alan H ^h   Virtanen, Jyrki K ⁱ   Rice, Glenn ^j  

^a Industrial Economics Incorporated   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c LAVAL UNIVERSITY   (Canada)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^f CLARK UNIVERSITY   (United States)

^g WASHINGTON STATE DEPARTMENT OF HEALTH   (United States)

^h University of Eastern Finland ^*

ⁱ UNIVERSITY OF EASTERN FINLAND   (Finland)

^j U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

more..

Author keywords

Cardiovascular; Dose response function; Health impact analysis; Mercury; Methylmercury; Myocardial infarction

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; METHYLMERCURY;

ACUTE HEART INFARCTION; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; ENVIRONMENTAL EXPOSURE; FISH; FOOD INTAKE; HAIR ANALYSIS; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; OUTCOME ASSESSMENT; OXIDATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 79955823012     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1003012     Document Type: Review

References (75)

1. Allen BC, Hack CE, Clewell HJ. 2007. Use of Markov Chain Monte Carlo analysis with a physiologically based pharmacokinetic model of methylmercury to estimate exposures in U.S. women of childbearing age. Risk Anal 27:947-959.
2. Al-Saleh I, Shinwari N, Mashhour A, Mohamed GD, Ghosh MA, Shammasi Z, et al. 2006. Cadmium and mercury levels in Saudi women and its possible relationship with hypertension. Biol Trace Elem Res 112:13-29.
3. Bartell SM, Ponce RA, Sanga RN, Faustman EM. 2000. Human variability in mercury toxicokinetics and steady state biomarker ratios. Environ Res 84:127-132.
4. Bélanger MC, Mirault ME, Dewailly E, Plante M, Berthiaume L, Noël M, et al. 2008. Seasonal mercury exposure and oxidant-antioxidant status of James Bay sport fishermen. Metabolism 57:630-636.
5. Berglund M, Lind B, Bjömerg KA, Palm B, Einarsson O Vahter M. 2005. Inter-individual variation of human mercury exposure biomarkers: a cross-sectional assessment. Environmental Health 4:20; doi:10.1186/1476-069X-4-20 [Online 3 October 2005].
6. Bjorkman L, Lundekvam BF, Laegreid T, Bertelsen BI, Morild I, Lilleng P, et al. 2007. Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study. Environ Health 6:30; doi: 10.1186/1476-069X-6-30 [Online 11 October 2007].
7. Briones AM, Touyz RM. 2010. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 12:135-142.
8. Budtz-Jørgensen E, Grandjean P, Jørgensen PJ, Weihe P, Keiding N. 2004. Association between mercury concentrations in blood and hair in methylmercury-exposed subjects at different ages. Environ Res 95:385-393.
9. Choi AL, Cordier S, Weihe P, Grandjean P. 2008. Negative confounding in the evaluation of toxicity: the case of methylmercury in fish and seafood. Crit Rev Toxicol 38:877-893.
10. Choi AL, Weihe P, Budtz-Jørgensen E, Jørgensen PJ, Salonen JT, Tuomainen TP, et al. 2009. Methylmercury exposure and adverse cardiovascular effects in Faroese whaling men. Environ Health Perspect 117:367-372.
11. Cortes-Maramba N, Reyes JP, Francisco-Rivera AT, Akagi H, Sunio R, Panganiban LC. 2006. Health and environmental assessment of mercury exposure in a gold mining community in western Mindanao, Philippines. J Environ Manage 81:126-134.
12. Dewailly E, Muckle G, Ayotte P, Valera B, Noel M. 2009. Contaminant exposure and emergence of cardio-vascular diseases in Inuit. In: Synopsis of Research Conducted under the 2008-2009 Northern Contaminant Program (Smith S, Stow J, Edwards J, eds). Ottawa, Canada:Ministry of Indian Affairs and Northern Development, 24-41.
13. Dórea JG, de Souza JR, Rodrigues P, Ferrari I, Barbosa AC. 2005. Hair mercury (signature of fish consumption) and cardiovascular risk in Munduruku and Kayabi Indians of Amazonia. Environ Res 97:209-219.
14. Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, et al. 2006. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 114:2850-2870.
15. Fillion M, Mergler D, Passos CJS, Larribe F, Lemire M, Guimarães JRD. 2006. A preliminary study of mercury exposure and blood pressure in the Brazilian Amazon. Environ Health 5:29; doi:10.1186/1476-069X-5-29 [Online 10 October 2006].
16. Garland M, Morris JS, Rosner BA, Stampfer MJ, Spate VL, Baskett CJ, et al. 1993. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 2:493-497.
17. 2+ pathway blockers differentially protect against methylmercury and mercuric chloride neurotoxicity. J Neurosci Res 66:135-145.
18. Gatti R, Belletti S, Uggeri J, Vettori MV, Mutti A, Scandroglio R, et al. 2004. Methylmercury cytotoxicity in PC12 cells is mediated by primary glutathione depletion independent of excess reactive oxygen species generation. Toxicology 204: 175-185.
19. Grandjean P, Murata K, Budtz-Jørgensen E, Weihe P. 2004. Cardiac autonomic activity in methylmercury neurotoxicity: 14-year follow-up of a Faroese birth cohort. J Pediatr 144:169-176.
20. Grotto D, de Castro MM, Barcelos GR, Garcia SC, Barbosa F. 2009. Low level and sub-chronic exposure to methylmercury induces hypertension in rats: nitric oxide depletion and oxidative damage as possible mechanisms. Arch Toxicol 83:653-662.
21. Grotto D, Valentini J, Fillion M, Passos CJ, Garcia SC, Mergler D, et al. 2010. Mercury exposure and oxidative stress in communities of the Brazilian Amazon. Sci Total Environ 408:806-811.
22. Guallar E, Sanz-Gallardo MI, van't Veer P, Bode P, Aro A, Gómez-Aracena J, et al. 2002. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 347:1747-1754.
23. Hagele TJ, Mazerik JN, Gregory A, Kaufman B, Magalang U, Kuppusamy ML, et al. 2007. Mercury activates vascular endothelial cell phospholipase D through thiols and oxidative stress. Int J Toxicol 26:57-69.
24. Hallgren CG, Hallmans G, Jansson JH, Marklund SL, Huhtasaari F, Schutz A, et al. 2001. Markers of high fish intake are associated with decreased risk of a first myocardial infarction. Br J Nutr 86:397-404.
25. Hastie TJ, Tibshirani RJ. 1990. Generalized Additive Models. Boca Raton, FL:CRC Press.
26. Hattis D. 2003. The conception of variability in risk analyses-developments since 1980. In: Risk Analysis and Society in the 21st Century: An Interdisciplinary Characterization of the Field (McDaniels T, Small MJ, eds). Cambridge, U.K.:Cambridge University Press, 15-45.
27. Huang YL, Cheng SL, Lin TH. 1996. Lipid peroxidation in rats administered with mercuric chloride. Biol Trace Elem Res 52:193-206.
28. Khan MA, Wang F. 2009. Mercury-selenium compounds and their toxicological significance: toward a molecular understanding of the mercury-selenium antagonism. Environ Toxicol Chem 28:1567-1577.
29. Kishimoto T, Oguri T, Abe M, Kajitani H, Tada M. 1995. Inhibitory effect of methylmercury on migration and tube formation by cultured human vascular endothelial cells. Arch Toxicol 69:357-361.
30. Lahiri MK, Kannankeril PJ, Goldberger JJ. 2008. Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol 51:1725-1733.
31. Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. 2008. Global burden of blood pressure-related disease, 2001. Lancet 371:1513-1518.
32. Lim S, Chung H-U, Paek D. 2009. Low dose mercury and heart rate variability among community residents nearby to an industrial complex in Korea. Neurotoxicology 31:10-16.
33. Lin TH, Huang YL, Huang SF. 1996. Lipid Peroxidation in liver of rats administered with methyl mercuric chloride. Biol Trace Elem Res 54:33-41.
34. Mahaffey KR, Clickner RP, Jeffries RA. 2008. Methylmercury and omega-3 fatty acids: co-occurrence of dietary sources with emphasis on fish and shellfish. Environ Res 107:20-29.
35. Mazerik JN, Hagele T, Sherwani S, Ciapala V, Butler S, Kuppusamy ML, et al. 2007. Phospholipase A2 activation regulates cytotoxicity of methylmercury in vascular endothelial cells. Int J Toxicol 26:553-569.
36. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, et al. 2004. Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol 24:e29-e50.
37. Mozaffarian D. 2009. Fish, mercury, selenium and cardiovascular risk: current evidence and unanswered questions. Int J Environ Res Public Health 6:1894-1916.
38. Mozaffarian D, Rimm EB. 2006. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296:1885-1899.
39. Murata K, Sakamoto M, Nakai K, Dakeishi M, Iwata T, Liu XJ, et al. 2006. Subclinical effects of prenatal methylmercury exposure on cardiac autonomic function in Japanese children. Int Arch Occup Environ Health 79:379-386.
40. NRC (National Research Council). 2000. Toxicological Effects of Methylmercury. Washington, DC:National Academy Press.
41. Ohba T, Kurokawa N, Nakai K, Shimada M, Suzuki K, Sugawara N, et al. 2008. Permanent waving does not change mercury concentration in the proximal segment of hair close to scalp. Tohoku J Exp Med 214:69-78.
42. Ohno M, Kishimoto T, Tada M. 1995. The effect of methylmercury (CH3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets. Cell Biol Toxicol 11:303-311.
43. Ohno T, Sakamoto M, Kurosawa T, Dakeishi M, Iwata T, Murata K. 2007. Total mercury levels in hair, toenail, and urine among women free from occupational exposure and their relations to renal tubular function. Environ Res 103:191-197.
44. Park ST, Lim KT, Chung YT, Kim SU. 1996. Methylmercury-induced neurotoxicity in cerebral neuron culture is blocked by antioxidants and NMDA receptor antagonists. Neurotoxicology 17:37-45.
45. Pedersen EB, Jørgensen ME, Pedersen MB, Siggaard C, Sørensen TB, Mulvad G, et al. 2005. Relationship between mercury in blood and 24-h ambulatory blood pressure in Greenlanders and Danes. Am J Hypertens 18(5 pt 1):612-618.
46. Peltz A, Sherwani SI, Kotha SR, Mazerik JN, O'Connor Butler ES, Kuppusamy ML, et al. 2009. Calcium and calmodulin regulate mercury-induced phospholipase D activation in vascular endothelial cells. Int J Toxicol 28:190-206.
47. Prozialeck WC, Grunwald GB, Dey PM, Reuhl KR, Parrish AR. 2002. Cadherins and NCAM as potential targets in metal toxicity. Toxicol Appl Pharmacol 182:255-265.
48. Rees JR, Sturup S, Chen C, Folt C, Karagas MR. 2007. Toenail mercury and dietary fish consumption. J Expo Science Environ Epidemiol 17:25-30.
49. Rice GE, Hammitt JK, Evans JS. 2010. A probabilistic characterization of the health benefits of reducing methyl mercury intake in the United States. Environ Sci Technol 44:5126-5224.
50. Salonen JT, Seppänen K, Lakka TA, Salonen R, Kaplan GA. 2000. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis 148:265-273.
51. Salonen JT, Seppänen K, Nyyssönen K, Korpela H, Kauhanen J, Kantola M, et al. 1995. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 91:645-655.
52. Seppänen K, Soininen P, Salonen JT, Lötjönen S, Laatikainen R. 2004. Does mercury promote lipid peroxidation? An in vitro study concerning mercury, copper, and iron in peroxidation of low-density lipoprotein. Biol Trace Elem Res 101:117-132.
53. Shipp AM, Gentry PR, Lawrence G, Van Landingham C, Covington T, Clewell HJ, et al. 2000. Determination of a site-specific reference dose for methylmercury for fish-eating populations. Toxicol Ind Health 16:335-438.
54. Sørensen N, Murata K, Budtz-Jørgensen E, Weihe P, Grandjean P. 1999. Prenatal methylmercury exposure as a cardiovascular risk factor at seven years of age. Epidemiology 10:370-375.
55. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. 2008. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr 21:93-111.
56. Stern AH. 2005. A review of the studies of the cardiovascular health effects of methylmercury with consideration of their suitability for risk assessment. Environ Res 98:133-142.
57. Swain EB, Jakus PM, Rice G, Lupi F, Maxson PA, Pacyna JM, et al. 2007. Socioeconomic consequences of mercury use and pollution. Ambio 36:45-61.
58. Tamashiro H, Arakaki M, Akagi H, Hirayama K, Murao K, Smolensky MH. 1986. Sex differential of methylmercury toxicity in spontaneously hypertensive rats. Bull Environ Contam Toxicol 37:916-924.
59. Thurston SW, Bovet P, Myers GJ, Davidson PW, Georger LA, Shamlaye C, et al. 2007. Does prenatal methylmercury exposure from fish consumption affect blood pressure in childhood? Neurotoxicology 28:924-930.
60. U.S. EPA. (Environmental Protection Agency). 1997. Mercury Study Report to Congress. Volume IV. An Assessment of Exposure to Mercury in the United States. Final Report. EPA-452/R-97/006. Washington, DC:U.S. Environmental Protection Agency.
61. U.S. EPA (Environmental Protection Agency). 2005. Regulatory Impact Analysis of the Final Clean Air Mercury Rule. EPA-452/R-05-003. Research Triangle Park, NC:U.S. Environmental Protection Agency.
62. Valera B, Dewailly E, Poirier P. 2008. Cardiac autonomic activity and blood pressure among Nunavik Inuit adults exposed to environmental mercury: a cross-sectional study. Environ Health 7:29; doi:10.1186/1476-069X-7-29 [Online 6 June 2008].
63. Valera B, Dewailly E, Poirier P. 2009a. Environmental mercury exposure and blood pressure among Nunavik Inuit adults. Hypertension 54:981-986.
64. Valera B, Dewailly E, Poirier P. 2010. Impact of toxic metals on blood pressure, resting heart rate and heart rate variability in an aboriginal population of Quebec (Canada) (Abstract). In: Proceedings of the Joint Conference-50th Cardiovascular Disease Epidemiology and Prevention-and-Nutrition, Physical Activity and Metabolism Conference. San Francisco, California. 2-5 March 2010.
65. Valera B, Dewailly E, Poirier P, Suhas E, Counil E. 2009b. Influence of mercury exposure on blood pressure and heart rate variability among French Polynesian adults [Abstract]. Can J Cardiol 25(suppl B):101.
66. Vander A, Sherman J, Luciano D. 2001. Human Physiology: The Mechanisms of Body Function. 8th ed. New York: McGraw-Hill.
67. Van Wagoner DR. 2008. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol 52:306-313.
68. Viger YB, Dewailly E, Egeland GM, Nieboer E, Pereg D. 2007. Environmental Health Study: Technical Report of Mistissini. Mistissini, Quebec, Canada:Public Health Department of the Cree Health Board.
69. Virtanen JK, Rissanen TH, Voutilainen S, Toumainen TP. 2007. Mercury as a risk factor for cardiovascular diseases. J Nutr Biochem 18:75-85.
70. Virtanen JK, Voutilainen S, Rissanen TH, Mursu J, Tuomainen TP, Korhonen MJ, et al. 2005. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscl Thromb Vas Biol 25:228-233.
71. Wakita Y. 1987. Hypertension induced by methylmercury in rats. Toxicol Appl Pharmacol 89:144-147.
72. Welsh SO. 1979. The protective effect of vitamin E and N,N'-diphenyl-p-phenylenediamine (DPPD) against methyl mercury toxicity in the rat. J Nutr 109:1673-1681.
73. Wennberg M, Bergdahl IA, Stegmayr B, Hallmans G, Lundh T, Skerfving S, et al. 2007. Fish intake, mercury, long-chain n-3 polyunsaturated fatty acids and risk of stroke in northern Sweden. Br J Nutr 98:1038-1045.
74. Yaginuma-Sakurai K, Murata K, Shimada M, Nakai K, Kurokawa N, Kameo S, et al. 2009. Intervention study on cardiac autonomic nervous effects of methylmercury from seafood. Neurotoxicol Teratol 32:240-245.
75. Yoshizawa K, Rimm EB, Morris JS, Spate VL, Hsieh CC, Spiegelman D, et al. 2002. Mercury and the risk of coronary heart disease in men. N Engl J Med 347:1755-1760